PuSH - Publication Server of Helmholtz Zentrum München

97 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Jaghutriz, B.A. et al.: Metabolomic characteristics of fatty pancreas. Exp. Clin. Endocrinol. Diabet., accepted (2019)
2.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
3.
Kempe-Teufel, D. et al.: A polygenic risk score of lipolysis-increasing alleles determines visceral fat mass and proinsulin conversion. J. Clin. Endocrinol. Metab. 104, 1090-1098 (2019)
4.
Linder, K. et al.: Dietary niacin intake predicts the decrease of liver fat content during a lifestyle intervention. Sci. Rep. 9:1303 (2019)
5.
Lutz, S.Z. et al.: The Gly385(388)arg polymorphism of the FGFR4 receptor regulates hepatic lipogenesis under healthy diet. J. Clin. Endocrinol. Metab. 104, 2041-2053 (2019)
6.
Lutz, S.Z. et al.: Sex-specific associations of testosterone with metabolic traits. Front. Endocrin. 10:90 (2019)
7.
Schork, A. et al.: Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: A prospective study using bioimpedance spectroscopy. Cardiovasc. Diabetol. 18:46 (2019)
8.
Stefan, N.: Neues zur nichtalkoholischen Steatohepatitis. Internist 60, 128-132 (2019)
9.
Willmann, C. et al.: Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: A randomized and controlled dietary intervention study. Am. J. Clin. Nutr. 109, 288-296 (2019)
10.
Eckel, N.* et al.: Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabet. Endocrinol. 6, 714-724 (2018)
11.
Fritsche, L. et al.: Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. Diabetes Res. Clin. Pract. 146, 251-257 (2018)
12.
Kantartzis, K. et al.: Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes. Metab. 20, 1793-1797 (2018)
13.
Kroeger, J.* et al.: Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)
14.
Lutz, S.Z. et al.: Single nucleotide polymorphisms in the G-protein coupled receptor kinase 5 (GRK5) gene are associated with plasma LDL-cholesterol levels in humans. Sci. Rep. 8:7745 (2018)
15.
Nuñez-Durán, E.* et al.: Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. Hepat. Commun. 2, 69-83 (2018)
16.
Randrianarisoa, E. et al.: Periaortic adipose tissue compared with peribrachial adipose tissue mass as markers and possible modulators of cardiometabolic risk. Angiology 69, 854-860 (2018)
17.
Siegel-Axel, D. et al.: Differences in extracellular matrix expression in pancreatic fat cells of non-diabetic, pre-diabetic and diabetic individuals. Diabetologia 61, S289-S290 (2018)
18.
Stefan, N.: Nonalcoholic fatty liver disease and mortality. Clin. Gastroenterol. Hepatol. 16, 1043-1045 (2018)
19.
Stefan, N. & Roden, M.*: Diabetes und Fettleber. Diabetol. Stoffwechs. 13, S205-S208 (2018)
20.
Willmann, C. et al.: Effects of increased fiber and reduced red meat intake, combined with caloric restriction, on cardiometabolic risk: A randomised and controlled dietary intervention study. Diabetologia 61, S78-S78 (2018)